mammary carcinoma


Also found in: Dictionary, Thesaurus, Encyclopedia.

mammary carcinoma

A term used for cytology preparations from breast aspirates which are clearly malignant, but for which it is impossible to say with certainty whether the cells seen are from invasive or in situ ductal carcinoma.
References in periodicals archive ?
Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.
Tumor classification was based on mammary carcinomas in female dogs, since there is no standardized classification described for cattle (GOLDSCHMIDT et al.
Association between ovarihysterectomy and feline mammary carcinoma.
Water-soluble derivates of propolis markedly reduced metastasis induced with transplantable mammary carcinoma cells (Orsolic et al.
The null hypothesis is not rejected for the images showing normal mammary tissue, but it is rejected for all ten images showing mammary carcinoma tissue, which means they are classified correctly.
One group described the absence of COX-2 gene in all 9 mammary carcinomas while the other group found 96% COX-2 gene expression in mammary tumors of cats (Millanta et al.
If superimposed classic, invasive mammary carcinoma is present, it is evident at low power by irregularly infiltrating glands, nests, and cords of cells extending beyond the fibrous wall of the lesion into the adjacent breast parenchyma (Figure 7, d).
Squamous-cell mammary carcinoma of predominantly fibrosarcoma-like structure.
Tubulo-lobular carcinoma is a rare variant of mammary carcinoma that displays both tubular and lobular patterns histologically with E-Cadherin reactivity of ductal immunophenotype.
Post-mastectomy angiosarcoma (Stewart-Treves syndrome) is usually a complication of the treatment of mammary carcinoma in which the angiosarcoma arises in association with lymphoedematous upper extremity.
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.
El-Mowafy of Mansoura University and associates administered 125 mg/kg of DHA, 250 mg/kg of DHA, cisplatin alone, cisplatin combined with DHA, or a control substance to groups of mice implanted with mammary carcinoma cells.